Article
An Immune-Related Clinical-Gene-Risk-Score (CGRS) prognosis Model for Bladder Cancer
2022-09-20
Abstract excerpt
<h4>Background: </h4> Immunotherapy for bladder cancer is prevalent, while efficacy is uncertain. To predict the outcomes of immunotherapy in bladder cancer patients, an immune-related prognosis model was conducted in this study. <h4>Methods: </h4> Single sample Gene Set Enrichment Analysis was used to delineate the landscape of the tumor immune microenvironment based on two independent public databases. Hierarch...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c60f942c-3b11-56ac-98d8-86455dcd72e7
- DOI
- 10.21203/rs.3.rs-1397810/v3
